Article

Deep brain stimulation

Department of Brain and Cognitive Sciences, University of Rochester, Rochester, New York, United States
Annual Review of Neuroscience (Impact Factor: 19.32). 02/2006; 29(1):229-57. DOI: 10.1146/annurev.neuro.29.051605.112824
Source: PubMed

ABSTRACT

Deep brain stimulation (DBS) has provided remarkable benefits for people with a variety of neurologic conditions. Stimulation of the ventral intermediate nucleus of the thalamus can dramatically relieve tremor associated with essential tremor or Parkinson disease (PD). Similarly, stimulation of the subthalamic nucleus or the internal segment of the globus pallidus can substantially reduce bradykinesia, rigidity, tremor, and gait difficulties in people with PD. Multiple groups are attempting to extend this mode of treatment to other conditions. Yet, the precise mechanism of action of DBS remains uncertain. Such studies have importance that extends beyond clinical therapeutics. Investigations of the mechanisms of action of DBS have the potential to clarify fundamental issues such as the functional anatomy of selected brain circuits and the relationship between activity in those circuits and behavior. Although we review relevant clinical issues, we emphasize the importance of current and future investigations on these topics.

Download full-text

Full-text

Available from: Jonathan W Mink
  • Source
    • "For dozens of years, neural electrodes that enabled the selective stimulation and recording of multiple independent neurons of the central neural system (CNS) or the peripheral neural system (PNS) have been expected to provide enhanced functioning of neural prosthetic devices. Some good examples of this are the treatment of spinal cord injuries and the subsequent rehabilitation [1] [2] [3], urinary incontinence [4] [5] [6], cochlear implants [7] [8] [9] [10], and deep brain stimulation (DBS) [11]. Furthermore, neurophysiologists use neural electrodes to investigate the physiological functions of the brain, such as brain-computer interfaces and brain-machine interfaces, by the practice of stimulating neurons and recording their responses [12] [13] [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper demonstrates a polyimide nerve cuff electrode with a controllable drug loading/release function for stable recording of peripheral nerve signals and stimulation and minimizing inflammation. For control of anti-inflammatory drug loading/release, dexamethasone (DEX)-loaded poly L-lactic acid (PLLA) and/or poly lactic-co-glycol acid (PLGA) nanofibers were deposited on a functional nerve cuff electrode by the electro-spinning method, which can control the weight of DEX loading on the functional nerve cuff electrode. Then, UV patternable polyethylene glycol (PEG) was coated on the functional nerve cuff with DEX-loaded nanofibers for the acceleration of the release rate of the drug. Through high performance liquid chromatography (HPLC), DEX release rates were increased from 16 to 28% (PLLA-loaded nanofibers) and from 68 to 87% (PLGA-loaded nanofibers) due to the increased diffusion rate of DEX after 28 days, respectively. In addition, the functional nerve cuff electrode was electro-polymerized with poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) (PEDOT:PSS) as a conductive polymer in order to recover the decreased electrical properties caused by PEG patterning. The impedance measured at 1 kHz was 342 Ω mm2, which was extremely lower than the value of 1046 Ω mm2 of PEG-patterned cuff electrodes. Through the acute ex-vivo test of SD rat's sciatic nerve, the functional nerve cuff electrode with PEDOT:PSS exhibited stable and effective recording of the nerve's signals despite PEG patterning.
    Full-text · Article · Aug 2015 · Sensors and Actuators B Chemical
  • Source
    • "Deep brain stimulation (DBS) has been shown to be effective in the treatment of movement disorders, such as Parkinson's disease and tremor (Kleiner-Fisman et al. 2006; Perlmutter & Mink, 2006). It has also been used in conditions as diverse as chronic pain and Tourette's syndrome (Bittar et al. 2005; Steeves et al. 2012). "

    Full-text · Conference Paper · May 2015
  • Source
    • "Numerous efforts have been made to understand the brain network and develop treatments for its disorders, as schizophrenia, Parkinson, Alzheimer, depression and addiction [1]. Advances in microsystem technology allowed the development of micrometer sized devices that access deep areas of the brain in order to understand neurophysiological processes and restore central nervous system's lost functionalities [2]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper synthesizes the development of a new 3D neuroprobe array, constituted by microelectrodes capable of electrical stimulation and recording. The array's design relies on a bulk silicon substrate dicing technology and it comprises 6 × 6 neuroprobes with three different penetrating lengths (from 3 to 4 mm) and a 180 μm cross-section. A reproducible fabrication method was demonstrated, capable of producing longer shafts than in previously reported arrays. In addition, sputtered titanium/iridium oxide microelectrodes have shown the required performance, with a consistent reversible electrochemical behavior and an impedance value of 145 in the same frequency range as the stimulation protocols.
    Full-text · Article · Apr 2015
Show more